Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya

Citation:
Omosa-Manyonyi GS, Anzala O, Jaoko W, Ogutu H, Wakasiaka S, Malogo R, Nyange J, Njuguna P, Ndinya-Achola JO, Bhatt K, Bashir F, Oyaro M, Schmidt C, Priddy F, Fast P. "Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya.". 2011.

Abstract:

With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the Kenya AIDS Vaccine Initiative (KAVI) at the University of Nairobi has conducted HIV vaccine clinical trials since 2001

UoN Websites Search